|1.||Lewis, J G: 9 articles (06/2015 - 07/2004)|
|2.||Torpy, D J: 8 articles (06/2015 - 05/2003)|
|3.||Lewis, John G: 7 articles (05/2015 - 11/2006)|
|4.||Ho, J T: 6 articles (01/2012 - 01/2006)|
|5.||Torpy, David J: 5 articles (05/2014 - 06/2007)|
|6.||Ho, Jui T: 4 articles (10/2011 - 06/2007)|
|7.||Shand, B I: 4 articles (04/2010 - 07/2004)|
|8.||Pugeat, Michel: 4 articles (06/2007 - 10/2002)|
|9.||Donihi, Amy C: 3 articles (11/2015 - 07/2009)|
|10.||Chapman, M J: 3 articles (06/2015 - 01/2006)|
07/01/1993 - "20 patients with phosphor burn (TBSA 2%-75%) were cured by i.v. drop of calcium gluconate combined with other therapies including eschar conservation. "
01/01/2014 - "This study was designed to evaluate the efficiency and safety of arterial infusions of calcium gluconate to treat hydrofluoric (HF) acid burns of the distal human limbs. "
01/01/2014 - "Eligible patients with HF burn limbs, collected from January 2008 to October 2011, were given the arterial infusion of calcium gluconate into the injured limbs. "
11/01/2009 - "Intra-arterial calcium gluconate might be considered for finger burns caused by concentrated HF. "
01/01/2009 - "We conclude that intra-arterial calcium gluconate injection is a successful and well-tolerated therapy for HF burn associated with Raynaud's syndrome. "
11/01/2005 - "One to 2 g of IV calcium gluconate were effective for most patients with mild hypocalcemia; however, treatment of moderate to severe hypocalcemia with 2-4 g of IV calcium gluconate was often unsuccessful. "
11/01/2005 - "One to 2 g of IV calcium gluconate was effective in normalizing iCa for 23 out of 29 patients (79%) with mild hypocalcemia and 2-4 g was effective for 3 of 8 patients (38%) with moderate to severe hypocalcemia. "
07/01/2015 - "To avoid the risk of hypocalcemia, calcium gluconate was infused to the venous return line. "
11/01/2014 - "Amount of calcium gluconate intravenous used, hypocalcemia and duration of hospital stay did not show any significance."
11/01/2014 - "No significant difference was observed in amount of calcium gluconate intravenous use, hypocalcemia and hospital admission durations between titrated and loaded regimen groups, i.e., p = 0.160, 0.645 and 0.460, respectively. "
05/01/2014 - "Calcium gluconate soaks appear to be effective in reducing local pain and tissue damage. "
08/01/2013 - "Reviews on spinal disorders or pain syndromes were found in the Cochrane Back Group (CBG) and in the Pain, Palliative and Supportive Care Group (CPPSCG). "
01/01/2009 - "Pain and vasospasm were successfully treated by repeated intra-arterial calcium gluconate injection. "
07/01/2002 - "Locally inject with 10% calcium gluconate solution if the pain persists. "
11/01/1997 - "Intraarterial calcium gluconate perfusion was subsequently administered to the three patients with persistent subungual and pulp, or thenar pain. "
12/01/2012 - "Infusion of calcium gluconate may reduce early-onset hyperkalemia in a dose-dependent manner."
12/01/2012 - "The dosage of calcium gluconate during 24 h after birth was the only independent factor affecting early-onset hyperkalemia. "
01/01/2008 - "[Persistent severe hyperkalemia treated with a continous infusion of calcium gluconate]."
01/01/2006 - "The hyperkalemia was quickly normalized by medication with calcium gluconate and sodium bicarbonate. "
12/01/1985 - "If life threatening hyperkalemia develops during acute renal failure, 20 ml 10% calcium gluconate solution can be given intravenously in order to avoid ventricular fibrillation or cardiac arrest. "
06/01/2015 - "Although CBG is known to exhibit anti-cancer activities, very little is known about its potential mechanism(s) of action. "
07/01/2011 - "Analysis of the gene signal pathway further approved that smad2 gene had the relationships closely to other 16 cancer-related genes and could be used as a CBG to indicate the carcinogenic risks in YZR-SDW-NJ. "
05/01/2011 - "Taken together, these results indicated that CBG had potential immune system regulatory effects and suggested that this compound could be developed as a novel immunotherapeutic agent to treat immune-mediated diseases such as cancer."
01/01/2010 - "The complete extension of the tumor is much easier to detect with the cbg technique due to orientation of the anatomic landmarks. "
12/01/2008 - "The maximum of tumor infiltration length in CBG, MTG, ATG and STG were 11.68 mm, 13.08 mm, 8.64 mm and 9.98 mm respectively. "
|1.||Hydrofluoric Acid (Hydrogen Fluoride)
|3.||Magnesium Sulfate (Sulfate, Magnesium)
|6.||Calcium Chloride (Calcium Chloride, Anhydrous)
|9.||Interleukin-6 (Interleukin 6)